Literature DB >> 19688254

Tyrosine administration decreases glutathione and stimulates lipid and protein oxidation in rat cerebral cortex.

Angela M Sgaravatti1, Alessandra S Magnusson, Amanda S de Oliveira, Andréa P Rosa, Caroline Paula Mescka, Fernanda R Zanin, Carolina D Pederzolli, Angela T S Wyse, Clóvis M D Wannmacher, Moacir Wajner, Carlos Severo Dutra-Filho.   

Abstract

Tyrosine levels are abnormally elevated in tissues and physiological fluids of patients with inborn errors of tyrosine catabolism especially in tyrosinemia type II which is caused by deficiency of tyrosine aminotransferase (TAT) and provokes eyes, skin and central nervous system disturbances. We have recently reported that tyrosine promoted oxidative stress in vitro but the exact mechanisms of brain damage in these disorder are poorly known. In the present study, we investigated the in vivo effect of L-tyrosine (500 mg/Kg) on oxidative stress indices in cerebral cortex homogenates of 14-day-old Wistar rats. A single injection of L-tyrosine decreased glutathione (GSH) and thiol-disulfide redox state (SH/SS ratio) while thiobarbituric acid-reactive substances, protein carbonyl content and glucose-6-phosphate dehydrogenase activity were enhanced. In contrast, the treatment did not affect ascorbic acid content, and the activities of superoxide dismutase, catalase and glutathione peroxidase. These results indicate that acute administration of L-tyrosine may impair antioxidant defenses and stimulate oxidative damage to lipids and proteins in cerebral cortex of young rats in vivo. This suggests that oxidative stress may represent a pathophysiological mechanism in hypetyrosinemic patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19688254     DOI: 10.1007/s11011-009-9153-6

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  36 in total

1.  Intellectual deficits after transient tyrosinemia in the term neonate.

Authors:  P Mamunes; P E Prince; N H Thornton; P A Hunt; E S Hitchcock
Journal:  Pediatrics       Date:  1976-05       Impact factor: 7.124

2.  Tyrosine aminotransferase isoenzyme deficiency.

Authors:  F Lemonnier; C Charpentier; M Odievre; M Larregue; A Lemonnier
Journal:  J Pediatr       Date:  1979-06       Impact factor: 4.406

3.  A specific and sensitive assay for disulfides.

Authors:  W L Zahler; W W Cleland
Journal:  J Biol Chem       Date:  1968-02-25       Impact factor: 5.157

Review 4.  Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment.

Authors:  B Halliwell
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

5.  Regional enzyme development in rat brain. Enzymes associated with glucose utilization.

Authors:  S F Leong; J B Clark
Journal:  Biochem J       Date:  1984-02-15       Impact factor: 3.857

6.  Oxidative damage to proteins: spectrophotometric method for carbonyl assay.

Authors:  A Z Reznick; L Packer
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

7.  Pharmacokinetics of systemically administered tyrosine: a comparison of serum, brain tissue and in vivo microdialysate levels in the rat.

Authors:  Rodolfo Bongiovanni; Bryan K Yamamoto; Catherine Simpson; George E Jaskiw
Journal:  J Neurochem       Date:  2003-10       Impact factor: 5.372

8.  Regional tyrosine levels in rat brain after tyrosine administration.

Authors:  M C Morre; F Hefti; R J Wurtman
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

Review 9.  Painful keratoderma and photophobia: hallmarks of tyrosinemia type II.

Authors:  L G Rabinowitz; L R Williams; C E Anderson; A Mazur; P Kaplan
Journal:  J Pediatr       Date:  1995-02       Impact factor: 4.406

Review 10.  The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies.

Authors:  M Wajner; A Latini; A T S Wyse; C S Dutra-Filho
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

View more
  20 in total

1.  Tyrosine impairs enzymes of energy metabolism in cerebral cortex of rats.

Authors:  Rodrigo Binkowski de Andrade; Tanise Gemelli; Denise Bertin Rojas; Cláudia Funchal; Carlos Severo Dutra-Filho; Clovis Milton Duval Wannmacher
Journal:  Mol Cell Biochem       Date:  2012-02-05       Impact factor: 3.396

2.  Evidence of hippocampal astrogliosis and antioxidant imbalance after L-tyrosine chronic administration in rats.

Authors:  Milena Carvalho-Silva; Lara M Gomes; Samira Dal-Toé de Prá; Leticia B Wessler; Patricia F Schuck; Giselli Scaini; Andreza Fabro de Bem; Carlos H Blum-Silva; Flávio H Reginatto; Jade de Oliveira; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2019-11-08       Impact factor: 3.584

3.  Omega-3 fatty acid supplementation decreases DNA damage in brain of rats subjected to a chemically induced chronic model of Tyrosinemia type II.

Authors:  Milena Carvalho-Silva; Lara M Gomes; Giselli Scaini; Joyce Rebelo; Adriani P Damiani; Maiara Pereira; Vanessa M Andrade; Fernanda F Gava; Samira S Valvassori; Patricia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2017-03-18       Impact factor: 3.584

4.  Antioxidants reverse the changes in energy metabolism of rat brain after chronic administration of L.-tyrosine.

Authors:  Brena P Teodorak; Giselli Scaini; Milena Carvalho-Silva; Lara M Gomes; Letícia J Teixeira; Joyce Rebelo; Samira D T De Prá; Neila Zeni; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2016-12-06       Impact factor: 3.584

5.  The characterization of neuroenergetic effects of chronic L-tyrosine administration in young rats: evidence for striatal susceptibility.

Authors:  Gabriela K Ferreira; Milena Carvalho-Silva; Lara M Gomes; Giselli Scaini; Leticia J Teixeira; Isabella T Mota; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2014-09-25       Impact factor: 3.584

6.  Omega-3 fatty acid supplementation can prevent changes in mitochondrial energy metabolism and oxidative stress caused by chronic administration of L-tyrosine in the brain of rats.

Authors:  Milena Carvalho-Silva; Lara M Gomes; Maria L Gomes; Bruna K Ferreira; Patricia F Schuck; Gustavo C Ferreira; Felipe Dal-Pizzol; Jade de Oliveira; Giselli Scaini; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2019-04-04       Impact factor: 3.584

7.  An evaluation of the effects of acute and chronic L-tyrosine administration on BDNF levels and BDNF mRNA expression in the rat brain.

Authors:  Gabriela K Ferreira; Giselli Scaini; Isabela C Jeremias; Milena Carvalho-Silva; Cinara L Gonçalves; Talita C B Pereira; Giovanna M T Oliveira; Luiza W Kist; Maurício R Bogo; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2013-10-04       Impact factor: 5.590

8.  Effect of L-tyrosine in vitro and in vivo on energy metabolism parameters in brain and liver of young rats.

Authors:  Gabriela K Ferreira; Giselli Scaini; Milena Carvalho-Silva; Lara M Gomes; Lislaine S Borges; Júlia S Vieira; Larissa S Constantino; Gustavo C Ferreira; Patrícia F Schuck; Emilio L Streck
Journal:  Neurotox Res       Date:  2012-07-31       Impact factor: 3.911

9.  L-tyrosine induces DNA damage in brain and blood of rats.

Authors:  Samira D T De Prá; Gabriela K Ferreira; Milena Carvalho-Silva; Júlia S Vieira; Giselli Scaini; Daniela D Leffa; Gabriela E Fagundes; Bruno N Bristot; Gabriela D Borges; Gustavo C Ferreira; Patrícia F Schuck; Vanessa M Andrade; Emilio L Streck
Journal:  Neurochem Res       Date:  2013-12-03       Impact factor: 3.996

10.  Creatine and pyruvate prevent the alterations caused by tyrosine on parameters of oxidative stress and enzyme activities of phosphoryltransfer network in cerebral cortex of Wistar rats.

Authors:  Rodrigo Binkowski de Andrade; Tanise Gemelli; Denise Bertin Rojas; Narielle Ferner Bonorino; Bruna May Lopes Costa; Cláudia Funchal; Carlos Severo Dutra-Filho; Clovis Milton Duval Wannmacher
Journal:  Mol Neurobiol       Date:  2014-06-25       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.